Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2023

Feb 11, 2023

34472_dirs_2023-02-10_7a974c68-1a6a-4855-8f5f-850339986006.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-02-08

Reporting Person: Pestano Gary Anthony (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-08 Common Stock M 5053 Acquired 97785 Direct
2023-02-09 Common Stock S 1852 $1.7991 Disposed 95933 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-08 Restricted Stock Units $ A 113021 Acquired Common Stock (113021) Direct
2023-02-08 Restricted Stock Units $ M 1378 Disposed Common Stock (1378) Direct
2023-02-08 Restricted Stock Units $ M 3675 Disposed Common Stock (3675) Direct

Footnotes

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.

F2: These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.

F3: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F5: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F6: These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.